US Patent Issued to QYUNS THERAPEUTICS on Aug. 5 for "Anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody and use thereof to treat disease" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,309, issued on Aug. 5, was assigned to QYUNS THERAPEUTICS Co. LTD. (Jiangsu, China).

"Anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody and use thereof to treat disease" was invented by Jiwan Qiu (Jiangsu, China), Yong Kong (Jiangsu, China), Wei Chen (Jiangsu, China), Huaiyao Qiao (Jiangsu, China), Yiliang Wu (Jiangsu, China), Tao Chen (Jiangsu, China) and Meijuan Wu (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present invention are an anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody and the use thereof. The monoclonal antibody has high affinity for human TSLP, has a neutralizing ac...